Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Pharmacology of lobeline, a nicotinic receptor ligand.

Damaj MI, Patrick GS, Creasy KR, Martin BR.

J Pharmacol Exp Ther. 1997 Jul;282(1):410-9.

2.

Antinociceptive and pharmacological effects of metanicotine, a selective nicotinic agonist.

Damaj MI, Glassco W, Aceto MD, Martin BR.

J Pharmacol Exp Ther. 1999 Oct;291(1):390-8.

3.
4.

Pharmacological investigation of (+)- and (-)-cis-2,3,3a,4,5,9b-hexahydro-1-methyl-1H-pyrrolo-[3,2-h]isoq uinoline, a bridged-nicotine analog.

Damaj MI, Glassco W, Marks MJ, Slobe B, James JR, May EL, Rosecrans JA, Collins AC, Martin BR.

J Pharmacol Exp Ther. 1997 Sep;282(3):1425-34.

5.

Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice.

Damaj MI, Fei-Yin M, Dukat M, Glassco W, Glennon RA, Martin BR.

J Pharmacol Exp Ther. 1998 Mar;284(3):1058-65.

6.

Regulation of brain nicotinic receptors by chronic agonist infusion.

Bhat RV, Turner SL, Selvaag SR, Marks MJ, Collins AC.

J Neurochem. 1991 Jun;56(6):1932-9.

PMID:
2027007
7.
8.

Effects of stimulation or blockade of central nicotinic-cholinergic receptors on performance of a novel version of the rat stimulus discrimination task.

Terry AV Jr, Buccafusco JJ, Jackson WJ, Zagrodnik S, Evans-Martin FF, Decker MW.

Psychopharmacology (Berl). 1996 Jan;123(2):172-81.

PMID:
8741940
9.

Pharmacological characterization of SIB-1663, a conformationally rigid analog of nicotine.

Rao TS, Sacaan AI, Menzaghi FM, Reid RT, Adams PB, Correa LD, Whelan KT, Vernier JM.

Brain Res. 2004 Apr 2;1003(1-2):42-53.

PMID:
15019562
11.

Functional diversity among 5-substituted nicotine analogs; in vitro and in vivo investigations.

Dukat M, Damaj IM, Young R, Vann R, Collins AC, Marks MJ, Martin BR, Glennon RA.

Eur J Pharmacol. 2002 Jan 25;435(2-3):171-80.

PMID:
11821023
12.

Effects of lobeline, a nicotinic receptor agonist, on learning and memory.

Decker MW, Majchrzak MJ, Arnerić SP.

Pharmacol Biochem Behav. 1993 Jul;45(3):571-6.

PMID:
8332618
13.

Effects of nicotinic acetylcholine receptor ligands on behavioral vigilance in rats.

Turchi J, Holley LA, Sarter M.

Psychopharmacology (Berl). 1995 Mar;118(2):195-205.

PMID:
7617808
14.

Involvement of spinal Met-enkephalin in nicotine-induced antinociception in mice.

Kiguchi N, Maeda T, Tsuruga M, Yamamoto A, Yamamoto C, Ozaki M, Kishioka S.

Brain Res. 2008 Jan 16;1189:70-7. Epub 2007 Nov 7.

PMID:
18048009
15.

Characterization and modulation of acute tolerance to nicotine in mice.

Damaj MI, Welch SP, Martin BR.

J Pharmacol Exp Ther. 1996 Apr;277(1):454-61.

PMID:
8613954
16.

Interaction of lobeline and nicotinic receptor ligands with the discriminative stimulus properties of cocaine and amphetamine.

Cunningham CS, Polston JE, Jany JR, Segert IL, Miller DK.

Drug Alcohol Depend. 2006 Oct 1;84(3):211-22. Epub 2006 Feb 24.

PMID:
16500038
17.

Ventral hippocampal alpha4beta2 nicotinic receptors and chronic nicotine effects on memory.

Bancroft A, Levin ED.

Neuropharmacology. 2000 Oct;39(13):2770-8.

PMID:
11044746
18.

Lobeline and structurally simplified analogs exhibit differential agonist activity and sensitivity to antagonist blockade when compared to nicotine.

Terry AV Jr, Williamson R, Gattu M, Beach JW, McCurdy CR, Sparks JA, Pauly JR.

Neuropharmacology. 1998;37(1):93-102.

PMID:
9680262
19.

Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.

Haghparast A, Khani A, Naderi N, Alizadeh AM, Motamedi F.

Pharmacol Biochem Behav. 2008 Feb;88(4):385-92. Epub 2007 Sep 19.

PMID:
17915302
20.

Pharmacological characterization of nicotine's interaction with cocaine and cocaine analogs.

Damaj MI, Slemmer JE, Carroll FI, Martin BR.

J Pharmacol Exp Ther. 1999 Jun;289(3):1229-36.

Supplemental Content

Support Center